GR1000074B - Lipoid vesicula for endoperitoneal supplying of therapeutical elements - Google Patents

Lipoid vesicula for endoperitoneal supplying of therapeutical elements

Info

Publication number
GR1000074B
GR1000074B GR880100233A GR880100233A GR1000074B GR 1000074 B GR1000074 B GR 1000074B GR 880100233 A GR880100233 A GR 880100233A GR 880100233 A GR880100233 A GR 880100233A GR 1000074 B GR1000074 B GR 1000074B
Authority
GR
Greece
Prior art keywords
vesicula
endoperitoneal
lipoid
therapeutical
supplying
Prior art date
Application number
GR880100233A
Other languages
Greek (el)
Other versions
GR880100233A (en
Inventor
Leroy L Richer
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Publication of GR880100233A publication Critical patent/GR880100233A/en
Publication of GR1000074B publication Critical patent/GR1000074B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Steroid Compounds (AREA)

Abstract

Περιγράφονται λιποσωματικά κυστίδια ενδεικνυόμενα για την ενίσχυση της παροχής θεραπευτικών παραγόντων στην περιτοναϊκή κοιλότητα, και μέθοδοι παρασκευής και χρήσεώς τους. ωDescribed are liposomal vesicles indicated for enhancing the delivery of therapeutic agents to the peritoneal cavity, and methods of their preparation and use. oh

GR880100233A 1987-04-06 1988-04-06 Lipoid vesicula for endoperitoneal supplying of therapeutical elements GR1000074B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/035,065 US4877619A (en) 1986-08-25 1987-04-06 Liposomal vesicles for intraperitoneal administration of therapeutic agents

Publications (2)

Publication Number Publication Date
GR880100233A GR880100233A (en) 1989-01-31
GR1000074B true GR1000074B (en) 1990-10-31

Family

ID=21880417

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100233A GR1000074B (en) 1987-04-06 1988-04-06 Lipoid vesicula for endoperitoneal supplying of therapeutical elements

Country Status (7)

Country Link
US (1) US4877619A (en)
EP (1) EP0345302A4 (en)
JP (1) JPH02502907A (en)
AU (1) AU1590988A (en)
CA (1) CA1320443C (en)
GR (1) GR1000074B (en)
WO (1) WO1988007853A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
ATE118168T1 (en) * 1990-12-03 1995-02-15 Vestar Inc PREVENTION OF SYNOVIAL ADHESION.
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US6806084B1 (en) * 1992-06-04 2004-10-19 The Regents Of The University Of California Methods for compositions for in vivo gene delivery
WO1995003035A1 (en) * 1993-07-23 1995-02-02 Massachusetts Institute Of Technology Polymerized liposomes with enhanced stability for oral delivery
US6004534A (en) * 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
US5746223A (en) * 1996-10-11 1998-05-05 Williams; Kevin Jon Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis
US5997899A (en) 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
ATE535232T1 (en) 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc SUSTAINED RELEASE OF LIPOSOMAL ANESTHETICAL COMPOSITIONS
JP4575592B2 (en) 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド Production of multivesicular liposomes
DE69940735D1 (en) 1998-07-17 2009-05-28 Pacira Pharmaceuticals Inc BIODEGRADABLE ARRANGEMENTS FOR THE CONTROLLED RELEASE OF INCLUDED SUBSTANCES
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
EP1356291B1 (en) * 2000-12-06 2011-05-04 Ecole Polytechnique Fédérale de Lausanne (EPFL) Method for production of a bioanalytical reagent, detection method based on use of said bioanalytical reagent, as well as the use of said method
CA2432319A1 (en) 2000-12-21 2002-07-18 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
AU2002257027A1 (en) * 2001-03-13 2002-09-24 Wayne State University Method of preventing adhesions with ifn-y
JP2004532252A (en) * 2001-05-31 2004-10-21 スカイファーマ インコーポレーテッド Encapsulation of nanosuspension in liposomes and microspheres
GB0200704D0 (en) * 2002-01-14 2002-02-27 Britannia Pharmaceuticals Ltd Use of phospholipids in peritoneal dialysis
US20030235610A1 (en) * 2002-06-21 2003-12-25 Piedmont Pharmaceuticals, Llc Liposomes containing biologically active compounds
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
ES2330295B1 (en) 2008-06-06 2010-09-23 Laboratorios Alcala Farma, Sl TOPIC FORMULATION OF IBUPROFEN.
US9713591B2 (en) 2008-10-07 2017-07-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
JP5476013B2 (en) * 2009-03-27 2014-04-23 株式会社ファンケル Topical skin preparation
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103260702B (en) 2010-10-28 2018-07-27 帕西拉制药有限公司 The sustained release preparation of non-steroid anti-inflammatory drug
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11529312B2 (en) 2016-04-07 2022-12-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use
CN109983013A (en) 2016-11-18 2019-07-05 帕西拉制药有限公司 Meloxicam zinc complexes particle multivesicular liposome preparation and preparation method thereof
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
DE2914788A1 (en) * 1979-04-11 1980-10-16 Nattermann A & Cie PARENTERAL APPLICABLE, STABLE DRUG SOLUTIONS WITH ANTI-INFLAMMATORY EFFECT
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US4619795A (en) * 1984-12-24 1986-10-28 Technicon Instruments Corp. Method for preparing lipid vesicles
DE3683606D1 (en) * 1985-11-27 1992-03-05 Ethicon Inc INHIBITION OF POST-OPERATIVE ADHAESION FORMATION BY TOPICAL ADMINISTRATION OF AN INFLAMMATORY-RESISTANT NON-STEROID ACTIVE SUBSTANCE.

Also Published As

Publication number Publication date
EP0345302A4 (en) 1990-02-20
CA1320443C (en) 1993-07-20
JPH02502907A (en) 1990-09-13
US4877619A (en) 1989-10-31
AU1590988A (en) 1988-11-04
GR880100233A (en) 1989-01-31
WO1988007853A1 (en) 1988-10-20
EP0345302A1 (en) 1989-12-13

Similar Documents

Publication Publication Date Title
GR1000074B (en) Lipoid vesicula for endoperitoneal supplying of therapeutical elements
AU587232B2 (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy
DE69505677D1 (en) LIPOSOMAL ADMINISTRATION SYSTEM FOR BIOLOGICALLY ACTIVE SUBSTANCES
FI924918A0 (en) ANORDINATION FOR THE CONSTRUCTION OF IONTOFORETISK ADMINISTRATION AV ETT CEILINGS
DK582487D0 (en) SMALL PARTICULARS AEROSOLLIPOSOM AND LIPOSOM MEDICINAL COMBINATIONS FOR MEDICAL USE
IT8547939A1 (en) LIPOSOMES CONTAINING INTERLEUCINE METHOD FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE IN CANCER DISEASES
GR71720B (en)
NZ195766A (en) Inhalation device for administration of powered medicament
NO884154D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PREPARATIONS.
AU2800689A (en) Differential delivery of therapeutic agents across the blood brain barrier
HUP0002521A2 (en) Onium salts of paclitaxel, process for producing them and medicaments comprising the same
GR1000490B (en) Preparation method of 4-ammonium derivatives of epipodophyllotoxinc glucosite
NZ503568A (en) Biphasic lipid vesicle composition for transdermal administration of an immunogen
EP0335133A3 (en) Drug delivery using pulmonary surfactant fo facilitate absorption
DK360188A (en) MEDICINE DELIVERY BODY
KR950700725A (en) Liposomal composition (LIPOSOME COMPOSITION)
HU907959D0 (en) Medical preparations
DE3851389T2 (en) Liposome delivery system for opoid analgesics.
MX9304133A (en) NEW DERIVATIVES OF PHOSPHOLIPIDS.
EP0389570A4 (en) High integrity liposomes and method of preration and use
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
ES8600055A1 (en) A procedure for co-encapsulating a liposome-drug preparation in lipid vesicles